enVVeno Medical (NVNO) FCF Margin (2017 - 2019)

enVVeno Medical's quarterly FCF Margin came in at 4786.21% in Q1 2019, up 44611.0% year-on-year from N/an in Q1 2018, and down 0.63% quarter-over-quarter from 4756.1% in Q4 2018.

enVVeno Medical has reported FCF Margin for 3 years, with the latest figure at 4786.21% in Q1 2019.

  • For the quarter ending Q1 2019, FCF Margin rose 44611.0% year-over-year to 4786.21%; the trailing twelve-month figure through Dec 2019 stood at 20037.42% (down 1662821.0% YoY), and the FY2019 full-year result was 20037.42%, down 1662375.0% from the prior year.
  • FCF Margin for Q1 2019 stood at 4786.21%, down from 4756.1% in the prior quarter.
  • The five-year high for FCF Margin was 730.85% in Q4 2017, with the low at 5232.32% in Q1 2018.
  • Average FCF Margin over 3 years is 3697.05%, with a median of 4337.59% recorded in 2017.
  • Year-over-year, FCF Margin tumbled 402525 bps in 2018 and jumped 44611 bps in 2019.
  • Tracing NVNO's FCF Margin over 3 years: stood at 730.85% in 2017, then sank by 551 bps to 4756.1% in 2018, then declined by 1 bps to 4786.21% in 2019.
  • The last three FCF Margin figures came in at 4786.21% (Q1 2019), 4756.1% (Q4 2018), and 4187.65% (Q3 2018), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 8.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 6.89%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 25.51%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 3.29%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -1.28%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.68%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 37.67%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 3.98%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.44%
10 enVVeno Medical 6.99 Mn 6.99 Mn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2019 -4,786.21%
Dec 31, 2018 -4,756.10%
Sep 30, 2018 -4,187.65%
Jun 30, 2018 -1,848.62%
Mar 31, 2018 -5,232.32%
Dec 31, 2017 -730.85%
Sep 30, 2017 -4,337.59%